Cancer care: Long battle for affordable treatment
Advances in oncology have improved treatment options, but their benefits remain out of reach for many patients who cannot afford to complete the prescribed course. This is despite the recent decision to cap trade margins on 137 identified non-scheduled anti-cancer medicines, providing some relief, writes Afshan Yasmeen...
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →